Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement

BMRA Stock  USD 0.32  0.01  3.23%   
About 72 percent of all Biomerica's investors are curious in acquiring. The analysis of overall sentiment of trading Biomerica stock suggests that a large number of investors are confidant at this time. The current market sentiment, together with Biomerica's historical and current headlines, can help investors time the market. In addition, many technical investors use Biomerica stock news signals to limit their universe of possible portfolio assets.
  
Dubai Healthcare Authority Granted Insurance Reimbursement for Biomericas EZ Detect Colon Disease Screening Test EZ Detect is a simple FDA cleared 2-minute at-home test that detects early warning signs of colorectal cancer, the third most common cancer worldwideAware is an FDA cleared simple at-home device clinically tested to increase sensitivity in breast self-exams about 80 percent of breast cancers are detected by women themselves noticing changes in their breastsFirst order placed for both Co

Read at finance.yahoo.com
Yahoo News
  

Biomerica Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Biomerica can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Biomerica Fundamental Analysis

We analyze Biomerica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biomerica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biomerica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Biomerica is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Biomerica Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biomerica stock to make a market-neutral strategy. Peer analysis of Biomerica could also be used in its relative valuation, which is a method of valuing Biomerica by comparing valuation metrics with similar companies.

Peers

Biomerica Related Equities

NPCENeuropace   9.90   
0%
100.0%
BBLGBone Biologics   4.80   
0%
48.0%
MOVEMovano   4.36   
0%
44.0%
TIVCTivic Health   4.00   
0%
40.0%
NXLNexalin Technology   2.09   
0%
21.0%
SRDXSurModics   0.58   
0%
5.0%
SGHTSight Sciences   0.75   
7.0%
0%
TNONTenon Medical   0.79   
7.0%
0%
SSKNSTRATA Skin   3.61   
36.0%
0%
AIMDAinos   4.26   
43.0%
0%
MODDModular Medical   4.76   
48.0%
0%

Complementary Tools for Biomerica Stock analysis

When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope